Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders)
Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders) is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2024-05-08. On CanQuery you can follow the original downloads. Files are available in English and French.
The Canadian product safety information for lorazepam and midazolam warn that they should not be used during pregnancy. The Canadian product safety information for phenobarbital warns that during pregnancy the drug’s benefit should be weighed against its risk. Also, restrictions for use in children vary from one drug to another.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2024-05-08
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders) (English, HTML) HTML · Download HTML
- Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders) (French, HTML) HTML · Download HTML